Title of Invention

"PROCESS FOR THE PREPARATION OF 1-OCTENE"

Abstract A process in two steps for the preparation of 1- octene starting from butadiene which comprises: a first step (a) in which the bis-hydrodimerization of butadiene to 1,7-octadiene is effected in the presence of a catalyst based on a palladium complex containing one or more tri-substituted monodentate phosphines, in an aprotic polar solvent optionally containing an organic base; a second step (b) in which the partial catalytic hydrogenation of 1,7-octadiene to 1-octene, is effected, the above process being characterized in that: (i) in the first step the aprotic polar solvent is selected from disubstituted cyclic ureas (ii) in the second step the catalyst is selected from non- supported ruthenium complexes having general formula (II): RuXmLn (II)
Full Text PROCESS FOR THE PREPARATION OF 1-OCTENE.
The present invention relates to a process for the preparation of 1-octene from butadiene in two steps, more specifically, a first step for the catalytic bis-hydrodimerization of butadiene to 1,7-octadiene in the presence of a hydrogen donor, in an aprotic polar solvent selected from disubstituted cyclic ureas, and a second step for the partial and selective reduction of 1,7-octadiene with hydrogen to 1-octene in the presence of a catalytic system comprising a non-supported ruthenium complex.
1-octene is widely applied in the field relating to the production of linear low density polyethylene (LLDPE), a copolymer obtained starting from ethylene and 1-olefins, as it imparts improved mechanical characteristics and a better weldability to the end-product. It is also applied in the field of plasticizers after hydroformylation, reduction to linear; alcohols arid esterif ication.
The synthesis of 1-octene starting from butadiene is known in the state of the art.
Some patents describe the synthesis of 1-octene from butadiene by means of a three-step process. In- US-A-5,030,792, in a first step the catalytic telomerization of butadiene is effected with acetic acid to give 2,7-octadienyl acetate; the latter, in a second step, is hydro-genated to n-octyl acetate which, in turn, in a third step, is pyrolyzed to 1-octene. This type of process is jeopardized by the high number of reaction steps and is also characterized by corrosion problems of the common materials linked to the use of acetic acid.
WO 92/10450 describes the catalytic telomerization of butadiene with an alcohol such as methanol or ethanol to give 2,7-octadienyl ether. The latter, in a second step, is hydrogenated to octyl ether which, in turn, in a third step, is pyrolyzed to 1-octene. Although it avoids the use of corrosive carboxylic acids, this type of process is also jeopardized by the high number of reaction steps and an overall lower selectivity.
Finally, WO 03/31378 describes the synthesis of 1-octene in only two steps starting from butadiene according to the scheme of equations (1) and (2)
In the first step of the process described, the catalytic bis-hydrodimerization of butadiene to 1,7-octadiene is effected with a reducing agent such as formic acid. In the second step, the partial catalytic hydrogenation is carried out, of 1,7-octadiene to 1-octene.
Although the process described in WO 03/31378 has the advantage, with respect to the previous processes, of reducing the number of steps necessary for producing 1-octene from butadiene, to two, it has numerous drawbacks and in particular the necessity of using, both in the first and in the second step, high quantities of costly noble metals as catalysts.
The first step of the process of WO 03/31378 is carried out according to a reaction known in literature, i.e. the bis-hydrodimerization of butadiene in the presence of formic acid and catalysts based on palladium and phosphines. The reaction described is, in all cases, scarcely selective, with the formation of mixtures of 1,6-octadiene and 1,7-octadiene; and the yields and catalytic efficiency, moreover, are low.
Furthermore, it is necessary to use high quantities of catalyst, which create problems relating to the cost and recovery of the catalyst itself. If the concentration of catalyst is reduced to lower values, the selectivity to 1,7-octadiene decreases.
From what is specified above, it would appear necessary to avail of a more efficient process for the hy-drodimerization of butadiene which allows high conversions and selectivities to 1,7-octadiene to be reached, also when operating with reduced concentrations of noble metal.
The second step of the process described in WO 03/31378 consists in the partial hydrogenation of 1,7-octadiene to 1-octane. The reaction, as described in WO 03/31378, i.e. carried out with a supported catalyst based on ruthenium irr heterogeneous phase, suffers from an extremely low catalytic activity. Very long reaction times, in the order of over 24 hours, are in fact required for obtaining a conversion of 1,7-octadiene of 70% and a selectivity to 1-octene of 60%, and furthermore, it does not avoid the formation of isomer olefins. Also in this case, the quantity of catalyst used (i.e. supported ruthenium) is much higher, due to the low catalytic activity of the catalyst adopted.
The necessity is therefore felt, also for this step, for a more efficient and more selective partial reduction of the 1,7-octadiene, even when operating with low quantities of catalyst.
A process has now been found for the preparation of 1-octene starting from butadiene, which overcomes the above drawbacks.
In accordance with this, the present invention relates to a process in two steps for the preparation of 1-octene starting from butadiene which comprises:
** a first step (a) in which the bis-hydrodimerization of butadiene to 1, 7-octadiene is effected in the presence of a catalyst based on a palladium complex containing one or more tri-substituted monodentate phosphines , in an aprotic polar solvent, optionally containing an organic base; the above first step being carried out in the presence of a hydrogen donor, preferably formic acid;
** a second step (b) in which the partial catalytic hydro-genation of 1, 7-octadiene, recovered at the end of the first step, to 1-octene, is effected; the above hydrogena-tion being carried out in an inert solvent, under hydrogen pressure or mixtures of hydrogen and nitrogen, in the presence of a catalyst;
the above process being characterized in that: (i) in the first step the aprotic polar solvent is selected from disubstituted cyclic ureas having general for-
mula (I)
(Figure Removed)
wherein n ranges from 1 to 8 , preferably from 2 to 3 ;
RI and R2, the same or different, are selected from H and a
Ci-C6 alkyl radical, preferably R^Rz^H;
R3 and R4, the same or different, are selected from Ci-Ci6, preferably Ci-C3, alkyl radicals
(ii) in the second step the catalyst is selected from nonsupported ruthenium complexes having general formula (II) :
RuXmLn (II), wherein:
X is selected from Cl, Br, I, CH3COO, H, =C(H)Ph; L is selected from monodentate or bidentate neutral ligands;
n ranges from 2 to 4 ; ra ranges from 1 to 3.
Typical examples of disubstituted cyclic ureas having general formula (I) are dimethyl ethylene urea (n=2; Ri-R2=:H; R3=R4-CH3) and dimethyl propylene urea (n=3; R1=R2=H; R3=R4=CH3) .
Using the particular solvents of the present invention in the first step, i.e. disubstituted cyclic ureas, it is possible, with all the other conditions remaining unaltered, to increase the conversion of butadiene and selectivity to 1,7-octadiene. This means that it is possible to decrease the quantity of catalyst used to extremely reduced concentrations, without reducing the conversion of butadiene and selectivity of 1,7-octadiene, which are maintained high.
gain with respect to the first step (a), i.e. the bis-hydrodimerization of butadiene to 1,7-octadiene, the palladium-based catalyst can be preformed or formed in situ. In the latter case, the catalyst is formed in situ starting from a palladium salt and one or more phosphines. In the preferred embodiment, the palladium salt is selected from palladium carboxylates, even more preferably from Pd(Me3CCOO)2 and Pd (acetate) 2 • As far as the phosphine is concerned, typical examples are triphenyl phosphine, tri(o-tolyl)phosphine, (3-sulfonatephenyl) diphenyl phosphine, tricyclohexyl phosphine, trimethyl phosphine, triethyl phosphine, triisopropyl phosphine, tributyl phosphine, and mixed phosphines methyl diphenyl phosphine, dimethyl phenyl phasphine, singly or combined with each other. Triphenyl phosphine is preferred. In the case of the formation in situ of the palladium complex, the molar ratio between the phosphines and palladium ranges from 1 to 100, preferably from 2 to 40.
In the preferred embodiment, the palladium is preformed and consists of one or more palladium complexes having the general formula PdX2(PR3)2, wherein X =C1, Br, acetate, and R3 is a C'l-Cis hydrocarbyl radical, preferably selected from phenyl, o-tolyl, methyl, tricylcohexyl, ethyl, isopropyl, butyl and relative mixtures. The following complexes are preferred: PdCl2 (PEt3) 2, PdCl2 (PCy3) 2/
PdCl2(PBut3)2, PdCl2 (PiPr3)?, wherein Et = ethyl, Cy = cyclo-hexyl, iPr -- isopropyl, But = n-butyl.
As far as the organic base which can be optionally used in the first step, is concerned, typical examples are pyridines, N-alkyl morpholines, trialkyl amines. In the preferred embodiment, the organic base is triethyl amine.
The first step is carried out in the presence of a hydrogen donor, preferably in a stoichiometric ratio of 1:2 molar with respect: to the butadiene, see equation (1), or slightly lower, The hydrogen donor is preferably formic acid.
The butadiene is used in an initial weight ratio ranging from 1:10 to 10:1 with respect to the solvent, more preferably from 1:5 to 5:1.
The hydrogen donor, preferably formic acid, is used, in a preferred embodiment, in a stoichiometric ratio (i.e. 1/2 molar) with respect to the butadiene, or slightly lower than the stoichiometric value.
The molar ratio between the organic base, for example triethyl amine and the hydrogen donor, for example formic acid, can vary from 0 to 1.5, more preferably from 0.2 to 1.3, arid even more preferably from 0.4 to 0.8.
Step (a) is carried out at temperatures ranging from 50 to 120°C, preferably from 70 to 100°C, preferably under a nitrogen pressure ranging from 0.5-2 MPa, more preferably
from 0.8 to 1.5 MPa.
The duration of the reaction of step (a) indicatively ranges from 10 to 180 minutes, more preferably from 15 to 120 minutes.
According to the above process, in the first step, it is possible to improve the selectivity to 1,7-octadiene even in the presence of extremely reduced quantities of catalyst, for example such that the initial molar ratio butadiene/palladium ranges from 5,000 to 1,000,000, preferably from 20,000 to 200,000, without significantly jeopardizing the conversion of the butadiene, which is maintained high.
At the end of the first step, the reaction product 1,7-octadiene can be recovered according to the conventional techniques. More specifically, in a preferred embodiment of the invention, the reaction product is separated by demixing, exploiting the fact that 1,7-octadiene is not rniscible in all ratios with disubstituted cyclic
The upper hydrocarbon phase, prevalently consisting of 1,7-octadiene, can be purified from the non-hydrocarbon residues by washing with water; the 1,7-octadiene is subse-cfuently purified with conventional methods, for example by distillation.
The second step of the process, i.e. the partial cata-
lytic hydrogenation of 1,7-octadiene to 1-octene, is carried out in the presence of a catalyst consisting of a ruthenium complex. The catalyst is preferably selected from ruthenium complexes having the formula RuXmLn, wherein: m ranges from 1 to 3, n ranges from 2 to 4; X = Cl, Br, I, CH3COO, H, =C(H)Ph; L = a monodentate neutral ligand such as: PPhj (Triphenyl phosphine) , PCy3 (Tricyclohexyl phosphine) , P (o-CH3C6H4) 3 (triortho-tolyl phosphine), CO (carbon monoxide) ; or L - a bidentate neutral ligand such as: diphenyl phosphine ethane (dppe), dipyridyl (bipy), 1,10-phenanthroline (Phen), 4.7-diphenyl-l,10-phen-anthroline (bato) , used alone or also combined with each other.
More specifically, the following ruthenium complexes are preferred: RuCl2 (PPh3) 3, RuCl2 (PPh3) 4, RuCl2(CO)(PPh3)3, RuHCl(PPh3)3, RuHCl(CO) (PPh3)3, RuCl2(dppe)2, RuCl2 (PCy3) 3, RuCl2(CO)2(PPh3)2, (PCy3)2Cl2Ru=C(H)Ph, [Ru (CO) 2C12]X. Among the most preferred catalysts, RuCl2(PPh3)x with x = 3 or 4, is used.
The ruthenium complex is added to the reaction mixture in a molar ratio, with respect to 1,7-octadiene, ranging from 1/100 to 1/500,000, preferably from 1/1,000 to 1/150,000, even more preferably from 1/5,000 to 1/50,000.
Step (b) can be carried out in a solvent or in the pure diene, preferably in the presence of a solvent. Suit-
able solvent's are alcohols having the general formula R-OH, wherein R is an alkyl radical containing from 1 to 6 carbon atoms; ethers R--0-R', wherein R and R' have the meaning described above for R; cyclic ethers containing up to 6 carbon atoms, linear or branched aliphatic hydrocarbons containing from 5 to 16 carbon atoms; partially or totally halogenated hydrocarbons containing from 1 to 3 carbon atoms, aromatic or alkyl aromatic hydrocarbons containing up to 9 carbon atoms; ketones containing up to 6 carbon atoms. The solvents are preferably selected from methanol, etha-riol, propanol arid mixtures thereof.
Mixtures of solvents non entirely miscible with each other can also be used as solvents, such as methanol and CS-CIG aliphatic hydrocarbons. The use of these mixtures of solvents simplifies the separation of the catalyst from the reaction mixture due to the greater affinity of the catalyst for the alcohol phase. In an even more preferred embodiment, the second step is carried out in a methanol solution, arid 1-octene (together with the possible non-reacted 1,7-octadiene and possible octane co-produced) can be extracted from the reaction mixture with a Cg-Cis aliphatic hydrocarbon, preferably dodecane, by means of liquid-liquid extraction according to the conventional techniques, leaving the catalyst, which can be recycled to the reaction, in the methanol solution. 1-octene is then recov-
ered from the hydrocarbon mixture, and purified with conventional methods.
When a solvent is used, the diene is contained in the solvent in a ratio ranging from 5 to 90% by weight, more preferably from 10 to 80% by weight.
The reaction of step (b) is generally carried out at a temperature ranging from 0°C to 150°C, preferably from 5 °C to 60°C. This range represents the temperature field in which the catalytic system has the minimum isomerization activity of the double bond compatible with a good hydiro-genation rate.
The reaction is generally carried out under a hydrocjen pressure or mixtures of hydrogen and nitrogen, preferably in the presence of hydrogen alone, at a pressure ranging from 0.05 to 10 MPa, preferably from 0,1 to 3 MPa.
The reaction time indicatively ranges from 2 to 200 minutes, more preferably from 5 to 60 minutes.
In order to limit the consecutive hydrogenation reaction of 1-octene to octane, the reaction is preferably carried out at a partial conversion of 1,7-octadiene lower than 80%, preferably ranging from 40 to 60%.
When the conversion value is within this range, selec-tiyities to 1-octene generally ranging from 75 to 90%, are obtained. Furthermore, when operating according to the invention, the other isomers of 1-octene and 1,7-octadiene
are normally absent.
The following examples are provided for a better understanding of the present invention.
EXAMPLES
Synthesis of 1,7-octadiene
Examples 1 to 14 (catalyst formed in situ)
The following products are placed, in the order indicated and in the type and quantities specified in Table 1 or hereunder, in a Hastelloy C autoclave having a volume of 300 ml and equipped with a mechanical stirring system and heating system: the solvent, the organic base (if present), 7 ml of formic acid (concentration 99% by weight) in a stoichiometric quantity with respect to the butadiene, triphenyl phosphine as ligand and Pd(CH3COO)2 as catalyst. Finally, the autoclave is closed and 20 g of butadiene are added. The autoclave is pressurized with nitrogen at 1.0 MPa and the heating is initiated to a temperature of 90°C for the time indicated in Table 1. At the end, the autoclave is cooled, the contents are treated with water and sodium bicarbonate and are extracted with cycloh.exane. The products are quantified by gas chromatography with the internal standard method. The conversion of butadiene and se-lectivities referring to the butadiene converted are indicated in Table 1.
(Table Removed)

NMP = N-methyl pyr roll done; THF = tetrahydrofuran; TMU = tetramethyl urea; DMEU = dimethyl ethylene urea; DMPU = dimethyl propylene urea.
Table 1 clearly shows how, when operating- with cyclic ureas as solvent, the other conditions remaining unaltered, the conversion of butadiene increases, whereas the selectivity to 1,7-octadiene remains the same or improves. Examples 15 to 20 (preformed catalyst)
The following products are placed, in the order indicated and in the type and quantities specified in Table 2 or hereunder, in a Hastelloy C autoclave having a volume of 300 ml and equipped with a mechanical stirring system and
heating system: 45 ml of solvent, 15 ml of triethyl amine, 7 ml of formic acid (.concentration 99% by weight) in a stoichiometric quantity with respect to the butadiene, and the catalyst in the molar ratio with respect to the butadiene specified in Table 2 . Finally, the autoclave is closed and 20 g of butadiene are added. The autoclave is pressurized with nitrogen at 1 MPa and the heating is initiated to a temperature of 90°C for 120 minutes. At the end, the autoclave is cooled, the contents are treated with water and sodium bicarbonate and are extracted with cyclohexane. The products are quantified by gas chromatography with the internal standard method. The conversion of butadiene and selectivities referring to the butadiene converted are indicated in Table 2 .
TABLE 2

(Table Removed)
Pbu3 - Tri-n-butyl phosphine; PET3 = Triethyl phosphine; = Tricyclohexyl phosphine.
Table 2 clearly shows that, when operating with cyclic ureas as solvent and using preformed palladium catalysts, with the other conditions remaining- unaltered, there is an increase in both the conversion of butadiene and also, to a lesser extent, the selectivity to 1 , 7-octadiene. Hydrogenation of 1,7-octadiene to L-octene Examples 21 to 25
100 ml of methanol, the quantity of 1,7-octadiene (1,7-OD) which is such as to reach the desired 1,7-OD/catalyst ratio, as indicated in Table 3 and 0.01 mmoles of catalyst are place in order into a 250 ml glass flask put under Argon, The solution is well mixed until the complete dissolution of the catalyst and is then transferred by means of a steel needle, exploiting the difference in pressure, to a. Hastelloy c autoclave having a volume of 300 ml, equipped with a mechanical stirring and heating system, previously brought under vacuum. Trie Argon pressure in the autoclave is brought to a level slightly higher than atmospheric value. The autoclave is heated (or cooled) to the desired temperature and hydrogen is then introduced by pressurizing the autoclave at a prressure of 2 MPa and connecting it to a make-up system of the used-up hydrogen. The reaction is thus initiated. A sample is taken from the autoclave at pre-established times and is analyzed by gas chromatography with the internal standard method to deter-
mine the residual 1, 7-octadiene of the 1-octene and 1-octane products and for the diene and monoene isomers. The selectivities refer to the 1,7-octadiene converted. The results obtained are indicated in Table 3.
TABLE 3

(Table Removed)
(a) effected in a solution of methanol /dodecane 1/1 by volume
Table 3 shows how, when operating according to the invention, in a solution of methanol, the hydrogenation reaction of 1,7-octadiene to 1-octene takes place in a few minutes, in relation to the concentration of catalyst, in the absence of the isomerization of 1,7-octadiene and 1-octene.





WE CLAIM:
1. A process in two steps for the preparation of 1- octene starting from butadiene which comprises:
a first step (a) in which the bis-hydrodimerization of butadiene to 1,7-octadiene is effected in the presence of a catalyst of the kind such as herein described based on a palladium complex containing one or more tri-substituted monodentate phosphines, in an aprotic polar solvent of the kind such as herein described optionally containing an organic base of the kind such as herein described; the above first step being carried out in the presence of a hydrogen donor of the kind such as herein described;
a second step (b) in which the partial catalytic hydrogenation of 1,7-octadiene, recovered at the end of the first step, to 1-octene, is effected; the above hydrogenation being carried out in an inert solvent, under hydrogen pressure or mixtures of hydrogen and nitrogen, in the presence of a catalyst;
the above process being characterized in that:
(i) in the first step the aprotic polar solvent is selected from disubstituted cyclic ureas having general formula (I)
(Formula Removed)
wherein n ranges from 1 to 8;
R1 and R2, the same or different, are selected from H and a C1-C6 alkyl radical;
R3 and R4, the same or different, are selected from C1-C16 alkyl radicals;
(ii) in the second step the catalyst is selected from non- supported ruthenium complexes having general formula (II):
(Formula Removed)
wherein:-
X is selected from C1, Br, I, CH3COO, H, =C(H)Ph;
L is selected from monodentate or bidentate neutral ligands;

m ranges from 1 to 3; n ranges from 2 to 4.
2. The process as claimed in claim 1, wherein in the compound having general formula (I), n is between 2 and 3; R1=R2=H; R3=R4=CH3.
3. The process as claimed in claim 1, wherein the palladium complex in step (a) is a preformed complex having the general formula PdX2(PR3)2 wherein X = Gl, Br, acetate, and R3 is a C1-C16 hydrocarbyl radical.
4. The process as claimed in claim 1, wherein the organic base used in step 1 is triethyl amine.
5. The process as claimed in claim 1, wherein the butadiene is used in an initial weight ratio with respect to the solvent ranging from 1:10 to 10:1.
6. The process as claimed in claim 5, wherein the butadiene is used in a weight ratio with respect to the solvent ranging from 1:5 to 5:1.
7. The process as claimed in claim 1, wherein the hydrogen donor is in a stoichiometric ratio of 1:2 molar with respect to the butadiene.
8. The process as claimed in claim 1, wherein the hydrogen donor is formic acid.
9. The process as claimed in claim 1, wherein the molar ratio between the organic base and hydrogen donor ranges from 0 to 1.5, more preferably from 0.2 to 1.3 and even more preferably from 0.4 to 0.8:
10. The process as claimed in claim 1, wherein step (a) is carried out at temperatures ranging from 50 to 120°C, preferably from 70 to 100°C.
11. The process as claimed in claim 1, wherein in the complex RuXmLn, m ranges from 2 to 3; n ranges from 2 to 4; x is selected from C1 and =CHPh; L is a phosphine.

12. The process as claimed in claim 11, wherein X = C1, m = 2, n = 4, L = PPh3.
13. The process as claimed in claim 11, wherein m - 3, n = 2 and L = PCy3.
14. The process as claimed in claim 1, wherein the ruthenium complex in step (b) is present in the reaction mixture in a molar ratio with respect to 1,7-octadiene, ranging from 1/100 to 1/500,000, preferably from 1/1,000 to 1/150,000, more preferably from 1/5,000 to 1/50,000.
15. The process as claimed in claim 1, wherein 1,7-octadiene is contained in the solvent in a ratio ranging from 5 to 90% by weight, more preferably from 10 to 80% by weight.
16. The process as claimed in claim 1, wherein step (b) is carried out at a temperature ranging from 0°C to 150°C, preferably from 5°C to 60°C.
17. The process as claimed in claim 1, wherein step (b) is carried out in the presence of mixtures of hydrogen and nitrogen, preferably in the presence of hydrogen alone, at a pressure ranging from 0.05 to 10 MPa, preferably from 0.1 to 3 MPa.

Documents:

2167-DELNP-2006-Abstract-(08-04-2011).pdf

2167-delnp-2006-Abstract.pdf

2167-DELNP-2006-Claims-(08-04-2011).pdf

2167-delnp-2006-claims.pdf

2167-DELNP-2006-Correspondence Others-(28-10-2011).pdf

2167-DELNP-2006-Correspondence-Others-(08-04-2011).pdf

2167-delnp-2006-correspondence-others-1.pdf

2167-delnp-2006-correspondence-others.pdf

2167-delnp-2006-description (complete).pdf

2167-delnp-2006-form-1.pdf

2167-delnp-2006-form-18.pdf

2167-delnp-2006-form-2.pdf

2167-delnp-2006-Form-3-(08-04-2011).pdf

2167-delnp-2006-form-3.pdf

2167-delnp-2006-form-5.pdf

2167-delnp-2006-gpa.pdf

2167-delnp-2006-pct-101.pdf

2167-delnp-2006-pct-210.pdf

2167-delnp-2006-pct-220.pdf

2167-delnp-2006-pct-237.pdf

2167-delnp-2006-pct-304.pdf

2167-delnp-2006-pct-308.pdf

2167-delnp-2006-Petition-137-(08-04-2011).pdf


Patent Number 255513
Indian Patent Application Number 2167/DELNP/2006
PG Journal Number 09/2013
Publication Date 01-Mar-2013
Grant Date 27-Feb-2013
Date of Filing 20-Apr-2006
Name of Patentee POLIMERI EUROPA S.P.A.
Applicant Address Via E. Fermi 4, I-72100 Brindisi, Italy.
Inventors:
# Inventor's Name Inventor's Address
1 DANIELE DELLEDONNE Via Romana 56, I-28047 Oleggio-Novara, Italy.
2 FRANCO RIVETTI Via Oglio 28, I-20139 Milan, Italy.
PCT International Classification Number C07C 2/40
PCT International Application Number PCT/EP2004/011460
PCT International Filing date 2004-10-11
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 MI2003A002085 2003-10-27 Italy